Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.5300
-0.0035 (-0.66%)
Dec 2, 2025, 9:36 AM EST
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $573.51 million as of December 2, 2025. Its market cap has decreased by -6.65% in one year.
Market Cap
573.51M
Enterprise Value
553.19M
Revenue
122.89M
Ranking
n/a
PE Ratio
41.00
Stock Price
$0.53
Market Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 573.51M, an increase of 5,889.55%. That is a compound annual growth rate of 16.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 573.51M | -0.78% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | 52.63M | -31.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 819.20M |
| Glass House Brands | 520.12M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 382.32M |
| Silence Therapeutics | 311.27M |
| Nika Pharmaceuticals | 259.91M |
| HST Global | 133.04M |